BCG Vaccine Benefit in Non–Muscle Invasive Bladder Cancer? - Medscape

Among patients with very high-risk but not high-risk disease, bacillus Calmette-Guérin more effectively delayed time to progression compared with transurethral resection of the bladder.

The bacillus Calmette-Guérin (BCG) vaccine nearly halved the risk of progression among patients with nonmuscle invasive bladder cancer (NMIBC) compared with transurethral resection of the bladder (TU… [+3292 chars]

full article...